Domains associated with nameserver ns1.amgenwebns.net

Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.

Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.

Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.

Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.

Biotechnology by Amgen educational program is about how we develop and manufacture high-quality, reliably available biologic medications. Our processes make us better.

Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.

KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.

Amgen is committed to partnering with innovators in the fight against serious illness. Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Business Development plays a critical role in the execution of Amgen’s growth strategy. From the early-stage innovations we fund through Amgen Ventures to the integration and alliance management work we engage in once an agreement is reached, Amgen Business Development is organized to effectively manage the process of working with partners every step of the way.

当社は、米国カリフォルニア州に本社を置く世界最大の独立バイオテクノロジー企業であるアムジェンと、日本に本社を置く研究開発型グローバル製薬企業であるアステラス製薬との合弁会社であり、2020年を目標にアムジェンの完全子会社として独立する予定です。 当社は、アムジェンのきわめて有望な化合物を、日本の医療ニーズに対する深い知識、マーケティングや開発・薬事に関する豊富な経験、および優れた科学的専門性を有するアステラス製薬と共同開発・共同商業化を行うことにより、日本の患者さんに貢献していきます。

Learn about clinical trial data for KYPROLIS® (carfilzomib)—treats relapsed or refractory multiple myeloma.

The Amgen Scholars Program provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading institutions.

Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.

Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.

Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).

Learn how investigational BiTE® antibodies can activate endogenous T cells to target malignant cells. Watch the proposed mechanism of BiTE® video.

Firma Amgen - wiodąca firma biotechnologiczna. Zapraszamy Państwa na witrynę firmy Amgen. Informacje na temat Amgen Sp. z o.o. oddział Warszawa

Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.

If you’re affected by migraine headache pain, you’re not alone. Read other’s stories, find new tools and understand migraine like never before.

EPOGEN® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis to reduce or avoid the need for red blood cell transfusions.

Find migraine disease data and information on migraine pathophysiology, as well as an understanding of current migraine management, here.

Biosimilars Scientific Complexities and Emerging Opportunities

Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.

Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.

Find psoriasis information, including types of psoriasis, symptoms, treatment options, patient stories, and more.

Learn more about preventing serious bone problems with XGEVA® (denosumab) injections.